No Excuses: US FDA Wants Early, Thorough Dosage Optimization For Cancer Drugs

 
• By Sue Sutter
Camera lens
US FDA wants sponsors to focus more attention on dosage optimization before submitting a marketing application. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards